ClinicalTrials.Veeva

Menu

Incidence of Macular Edema in a Uveitis Population

A

Aalborg University Hospital

Status

Active, not recruiting

Conditions

Non-infectious Uveitis
Macular Edema

Treatments

Drug: Local and systemical treatment

Study type

Observational

Funder types

Other

Identifiers

NCT06686641
ML45555

Details and patient eligibility

About

Macular edema from uveitis is a serious condition that can lead to vision loss. Uveitis is an inflammation inside the eye, and macular edema is when fluid builds up in the central part of the retina, called the macula, which is crucial for clear vision. This fluid buildup can blur vision, sometimes severely. Managing this condition can be challenging and may require several treatments to reduce the fluid and protect sight. While we know macular edema is a common cause of vision loss in uveitis, there's limited data on how often it affects people in Europe

Enrollment

1,550 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospital-admitted patients in the North Denmark Region with non-infectious uveitis.
  • Both juvenile and adult patients.
  • Diagnosed with non-infectious uveitis by a medical doctor.
  • Patients presenting with unspecific macular edema may be included if medical records indicate uveitis as the cause of the edema.

Exclusion criteria

  • Patients incorrectly classified as having uveitis based on their medical records (no confirmed diagnosis of uveitis).
  • Patients with infectious uveitis.
  • Macular edema due to other cause than uveitis will not count as uveitis associated edema

Trial design

1,550 participants in 1 patient group

Non-infectious uveitis patients treated at a hospitals in the North Denmark Region
Treatment:
Drug: Local and systemical treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems